Defective expression of ataxia telangiectasia mutated (ATM) as a cause of p53 dysfunction in B-cell chronic lymphocytic leukemia (CLL).

被引:0
|
作者
Pettitt, AR
Stankovic, T
Sherrington, PD
Stewart, GS
Cawley, JC
Taylor, AM
机构
[1] Univ Liverpool, Dept Haematol, Liverpool L69 3BX, Merseyside, England
[2] Univ Birmingham, Inst Canc Studies, CRC, Birmingham B15 2TT, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2192
引用
收藏
页码:490A / 490A
页数:1
相关论文
共 50 条
  • [1] p53 dysfunction in B-cell chronic lymphocytic leukemia:: inactivation of ATM as an alternative to TP53 mutation
    Pettitt, AR
    Sherrington, PD
    Stewart, G
    Cawley, JC
    Taylor, AMR
    Stankovic, T
    BLOOD, 2001, 98 (03) : 814 - 822
  • [2] Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
    Stankovic, T
    Weber, P
    Stewart, G
    Bedenham, T
    Murray, J
    Byrd, PJ
    Moss, PAH
    Taylor, AMR
    LANCET, 1999, 353 (9146): : 26 - 29
  • [3] The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells
    Navrkalova, Veronika
    Sebejova, Ludmila
    Zemanova, Jana
    Jaskova, Zuzana
    Trbusek, Martin
    LEUKEMIA & LYMPHOMA, 2013, 54 (08) : 1840 - 1843
  • [4] The prognostic significance of ataxia-telangiectasia-mutated (ATM) and p53 expression in breast cancer
    Suh, K. J.
    Ryu, H. S.
    Lee, K-H
    Im, S-A
    Kim, T-Y
    Kim, H.
    Yang, Y.
    Moon, H-G
    Han, S-W
    Oh, D-Y
    Han, W.
    Kim, T-Y
    Park, I. A.
    Noh, D-Y
    Bang, Y-J
    CANCER RESEARCH, 2016, 76
  • [5] The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    J Boysen
    S Sinha
    T Price-Troska
    S L Warner
    D J Bearss
    D Viswanatha
    T D Shanafelt
    N E Kay
    A K Ghosh
    Leukemia, 2014, 28 : 451 - 455
  • [6] The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    Boysen, J.
    Sinha, S.
    Price-Troska, T.
    Warner, S. L.
    Bearss, D. J.
    Viswanatha, D.
    Shanafelt, T. D.
    Kay, N. E.
    Ghosh, A. K.
    LEUKEMIA, 2014, 28 (02) : 451 - 455
  • [7] PROGRESSIVE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA FREQUENTLY EXHIBITS ABERRANT P53 EXPRESSION
    AGUILARSANTELISES, M
    MAGNUSSON, KP
    WIMAN, KG
    MELLSTEDT, H
    JONDAL, M
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) : 474 - 479
  • [8] p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis
    Cordone, I
    Masi, S
    Mauro, FR
    Soddu, S
    Morsilli, O
    Valentini, T
    Vegna, ML
    Guglielmi, C
    Mancini, F
    Giuliacci, S
    Sacchi, A
    Mandelli, F
    Foa, R
    BLOOD, 1998, 91 (11) : 4342 - 4349
  • [9] Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia
    Del Principe, MI
    Del Poeta, G
    Venditti, A
    Buccisano, F
    Maurillo, L
    Marini, R
    Cox, MC
    Panetta, P
    Suppo, G
    Degan, M
    Bruno, A
    Gattei, V
    Amadori, S
    HAEMATOLOGICA, 2004, 89 (12) : 1468 - 1475
  • [10] Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage
    Stankovic, T
    Stewart, GS
    Fegan, C
    Biggs, P
    Last, J
    Byrd, PJ
    Keenan, RD
    Moss, PAH
    Taylor, AMR
    BLOOD, 2002, 99 (01) : 300 - 309